Status:
COMPLETED
Arteriovenous Fistula Maturation Evaluation Study. FAME Study
Lead Sponsor:
Medifil AE
Collaborating Sponsors:
National and Kapodistrian University of Athens
Democritus University of Thrace
Conditions:
End-stage Renal Disease
Hemodialysis Access Failure
Eligibility:
All Genders
18-95 years
Brief Summary
Study of the features of hemodynamic and clinical maturation of the native arteriovenous fistula for hemodialysis.
Detailed Description
This is a prospective, single-center, observational study, investigating the clinical and hemodynamic features of maturation of hemodialysis native arteriovenous fistula (AVF). Hemodynamic features un...
Eligibility Criteria
Inclusion
- Hemodialysis patients
- new native arteriovenous fistula (AVF)
Exclusion
- Patients not eligible for AVF creation
- Patients with non compensated heart failure New York Heart Association stages 3 and 4
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2022
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04736875
Start Date
February 1 2019
End Date
February 20 2022
Last Update
March 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mediterranean Hospital
Glyfada, Attica, Greece, 16675